Breast Cancer Canada announces $500K in new grant funding
01 déc. 2022 13h58 HE
|
Breast Cancer Canada
SARNIA, Ontario, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Breast Cancer Canada today announced a call for proposals for their 2023 Precision Oncology Research Grants which will award $500,000 in new...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
30 nov. 2022 05h48 HE
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project
16 nov. 2022 08h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas,...
FRED’S TEAM MAKES HISTORY BY RAISING $100 MILLION FOR CANCER RESEARCH
03 nov. 2022 09h00 HE
|
Memorial Sloan Kettering Cancer Center
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research. Since 1995, runners have joined...
Florida Cancer Specialists & Research Institute Leaders Serve on Faculty for Value-Based Cancer Care Summit
19 oct. 2022 14h00 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Fort Myers, Fla., October 19, 2022 – Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for...
Prelude Therapeutics Receives FDA Clearance of IND for PRT3789, a Potent and Selective First-in-Class SMARCA2 Protein Degrader
18 oct. 2022 08h00 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that the U.S. Food and...
Global Oncology Nutrition Market Report 2022: A $2.13 Billion Market in 2026 Featuring B. Braun Melsungen, Danone India, Abbott Laboratories, Nestle, Victus
06 oct. 2022 06h13 HE
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global oncology nutrition market is...
Science Crossing Borders: Celebrating the Contributions of Immigrant Scientists
05 oct. 2022 09h45 HE
|
The Vilcek Foundation
NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- They come from around the world—born in Taiwan, India, Lebanon, Israel, Romania, and Russia, among other places—but they all call the United States home....
Global Cell Culture Market to Surpass US$ 33,452.8 Million by 2030, Says Coherent Market Insights (CMI)
29 sept. 2022 09h15 HE
|
CMI
Seattle, Sept. 29, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cell culture market is estimated to be valued at US$ 19,198.0 million in 2022 and is expected to exhibit...
Elevar Therapeutics Announces Camrelizumab Plus Rivoceranib Significantly Prolonged Overall Survival and Progression-Free Survival Versus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma During Phase 3 Trial, a Joint Program With Hengrui Pharma
10 sept. 2022 04h00 HE
|
Elevar Therapeutics
Top-line findings were presented today at the annual European Society for Medical Oncology (ESMO) Congress This is the first positive pivotal trial to show survival benefits with a PD-1 inhibitor...